Camlin Fine Sciences has received an approval to issue and allot 1,72,41,379 Equity Shares of face value Re 1 each to eligible qualified institutional buyers at the issue price of Rs 87 per Equity Share, aggregating to Rs 150 crore. The Security Issue and QIP Committee of the Company at its meeting held on November 23, 2017, approved the same.
Camlin Fine Sciences is the world's second largest manufacturer and marketer of food grade antioxidants BHA (butylated hydroxyanisole) and TBHQ (Tertiary Butylhydroquinone).
